November 19, 2026

Online Shop Review

Online Shop and Product Review

Sanofi Gets Priority U.S. FDA Review for Sutimlimab Product

1 min read

Sanofi Gets Priority U.S. FDA Review for Sutimlimab Product

French healthcare company Sanofi said on Thursday that the U.S. Food & Drug Administration (FDA) regulator had granted a priority review for Sanofi’s sutimlimab product, which treats hemolysis in adults suffering from cold agglutinin disease.

Read More…

Leave a Reply

Your email address will not be published. Required fields are marked *